These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2498457)

  • 21. The effect of LDL and modified LDL on macrophage secretion products.
    Prescott MF; Müller KR; Flammer R; Feige U
    Agents Actions Suppl; 1984; 16():163-70. PubMed ID: 6091426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation.
    Malle E; Ibovnik A; Leis HJ; Kostner GM; Verhallen PF; Sattler W
    Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):377-84. PubMed ID: 7749848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage released proteoglycans are involved in cell-mediated aggregation of LDL.
    Maor I; Aviram M
    Atherosclerosis; 1999 Jan; 142(1):57-66. PubMed ID: 9920506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of oxidized low density lipoproteins on ADP-induced platelet aggregation in plasma].
    Vlasova II; Vakhrusheva TV; Azizova OA; Lopukhin IuM
    Vopr Med Khim; 1998; 44(1):43-54. PubMed ID: 9575612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor activities for low-density lipoprotein and acetylated low-density lipoprotein in a mouse macrophage cell line (IC21) and in human monocyte-derived macrophages.
    Traber MG; Defendi V; Kayden HJ
    J Exp Med; 1981 Dec; 154(6):1852-67. PubMed ID: 6274992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal by high-density lipoprotein of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets.
    Mehta JL; Chen LY
    J Lab Clin Med; 1996 Mar; 127(3):287-95. PubMed ID: 9273362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated platelets secrete a protein-like factor that stimulates oxidized-LDL receptor activity in macrophages.
    Fuhrman B; Brook GJ; Aviram M
    J Lipid Res; 1991 Jul; 32(7):1113-23. PubMed ID: 1940635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies.
    Aviram M; Dankner G; Cogan U; Hochgraf E; Brook JG
    Metabolism; 1992 Mar; 41(3):229-35. PubMed ID: 1542259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation.
    Aviram M; Eias K
    Ann Nutr Metab; 1993; 37(2):75-84. PubMed ID: 8517637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of HepG2 cell-derived apolipoprotein A-I-containing lipoproteins on cholesteryl ester accumulation in macrophages.
    Kawano T; Hakamata H; Ohta T; Ding Y; Yoshida M; Ueda S; Horiuchi S
    Biochemistry; 1997 Aug; 36(32):9816-25. PubMed ID: 9245414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the effect of plasma lipoproteins on platelet function in vitro.
    Aviram M; Brook JG
    Haemostasis; 1983; 13(6):344-50. PubMed ID: 6421681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.
    Fogelman AM; Shechter I; Seager J; Hokom M; Child JS; Edwards PA
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2214-8. PubMed ID: 6769124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet interaction with high and low density lipoproteins.
    Aviram M; Brook JG
    Atherosclerosis; 1983 Mar; 46(3):259-68. PubMed ID: 6847742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects.
    Shmulewitz A; Brook JG; Aviram M
    Biochem J; 1984 Nov; 224(1):13-20. PubMed ID: 6508753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulating effect of biologically modified low density lipoproteins on ADP-induced aggregation of washed platelets persists in absence of specific binding.
    Volf I; Roth A; Moeslinger T; Cooper J; Schmid W; Zehetgruber M; Koller E
    Thromb Res; 2000 Mar; 97(6):441-9. PubMed ID: 10704653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycolaldehyde-modified low density lipoprotein leads macrophages to foam cells via the macrophage scavenger receptor.
    Jinnouchi Y; Sano H; Nagai R; Hakamata H; Kodama T; Suzuki H; Yoshida M; Ueda S; Horiuchi S
    J Biochem; 1998 Jun; 123(6):1208-17. PubMed ID: 9604012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet secretory products enhance LDL receptor activity and inhibit scavenger receptor activity in human monocyte derived macrophages.
    Aviram M
    Metabolism; 1989 May; 38(5):425-30. PubMed ID: 2725280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of platelet secretory products in modified lipoprotein metabolism in macrophages.
    Hayashi T; Naito M; Kuzuya M; Funaki C; Tateishi T; Asai K; Kuzuya F
    Artery; 1989; 16(5):248-62. PubMed ID: 2764730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages.
    Geng YJ; Hansson GK
    J Clin Invest; 1992 Apr; 89(4):1322-30. PubMed ID: 1556191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoregulation of the modified low density lipoprotein receptor in human monocyte-derived macrophages.
    Mazzone T; Chait A
    Arteriosclerosis; 1982; 2(6):487-92. PubMed ID: 6295350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.